Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

The natural course of cutaneous melanoma.

Leiter U, Meier F, Schittek B, Garbe C.

J Surg Oncol. 2004 Jul 1;86(4):172-8. Review.

PMID:
15221923
2.

Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.

Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, Garbe C.

Br J Dermatol. 2002 Jul;147(1):62-70.

PMID:
12100186
3.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
4.

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R.

Melanoma Res. 2007 Dec;17(6):393-9.

PMID:
17992123
5.

Are locoregional cutaneous metastases in melanoma predictable?

Borgstein PJ, Meijer S, van Diest PJ.

Ann Surg Oncol. 1999 Apr-May;6(3):315-21.

PMID:
10340893
6.

[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].

Eigentler TK, Radny P, Kamin A, Weide B, Caroli UM, Garbe C.

J Dtsch Dermatol Ges. 2005 Aug;3(8):592-8. Review. German.

PMID:
16033477
7.

Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.

Wobser M, Siedel C, Schrama D, Bröcker EB, Becker JC, Vetter-Kauczok CS.

Arch Dermatol Res. 2006 Feb;297(8):352-7. Epub 2006 Jan 3.

PMID:
16395613
8.

Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.

Francken AB, Accortt NA, Shaw HM, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF.

Ann Surg Oncol. 2008 May;15(5):1476-84. doi: 10.1245/s10434-007-9717-9. Epub 2008 Jan 15.

PMID:
18196345
9.

Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement.

Claessens N, Piérard GE, Piérard-Franchimont C, Arrese JE, Quatresooz P.

Melanoma Res. 2005 Apr;15(2):107-10.

PMID:
15846143
10.

From tumor lymphangiogenesis to lymphvascular niche.

Hirakawa S.

Cancer Sci. 2009 Jun;100(6):983-9. doi: 10.1111/j.1349-7006.2009.01142.x. Epub 2009 Feb 20. Review.

11.

Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.

Sartore L, Papanikolaou GE, Biancari F, Mazzoleni F.

Int J Surg. 2008 Jun;6(3):205-9. doi: 10.1016/j.ijsu.2008.03.003. Epub 2008 Mar 12.

12.

Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.

Pawlik TM, Ross MI, Johnson MM, Schacherer CW, McClain DM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE.

Ann Surg Oncol. 2005 Aug;12(8):587-96. Epub 2005 Jun 16.

PMID:
16021533
13.

Metastatic spread of stage I melanoma of the skin.

[No authors listed]

Tumori. 1983 Oct 31;69(5):449-54.

PMID:
6649071
14.

Cutaneous melanoma: role of ultrasound in the assessment of locoregional spread.

Catalano O, Siani A.

Curr Probl Diagn Radiol. 2010 Jan-Feb;39(1):30-6. doi: 10.1067/j.cpradiol.2009.04.001. Review.

PMID:
19931111
15.

[Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma].

Tejera-Vaquerizo A, Barrera-Vigo MV, Fernández-Canedo I, Blázquez-Sánchez N, Mendiola-Fernández M, Fernández-Orland A, Bosch-García R, de Troya-Martín M, Herrera-Ceballos E.

Actas Dermosifiliogr. 2007 Oct;98(8):531-8. Spanish.

PMID:
17919427
16.

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.

Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.

Eur J Surg Oncol. 2008 Jan;34(1):82-8. Epub 2007 Mar 13.

PMID:
17360144
17.

Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.

Gannon CJ, Rousseau DL Jr, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE.

Cancer. 2006 Dec 1;107(11):2647-52.

18.

A new American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Houghton A Jr, Kirkwood JM, Mihm MF, Morton DL, Reintgen D, Ross MI, Sober A, Soong SJ, Thompson JA, Thompson JF, Gershenwald JE, McMasters KM.

Cancer. 2000 Mar 15;88(6):1484-91.

PMID:
10717634
19.

The revised American Joint Committee on Cancer staging system for melanoma.

Thompson JA.

Semin Oncol. 2002 Aug;29(4):361-9.

PMID:
12170439
20.

High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.

van Akkooi AC, de Wilt JH, Verhoef C, Graveland WJ, van Geel AN, Kliffen M, Eggermont AM.

Eur J Cancer. 2006 Feb;42(3):372-80. Epub 2006 Jan 5.

PMID:
16403622
Items per page

Supplemental Content

Write to the Help Desk